Certara, Inc., a leading figure in model-informed drug development, has launched CoAuthor, a sophisticated regulatory writing programme designed specifically for medical writers. This cutting-edge platform combines generative AI capabilities with document templates, Microsoft Word capability, and tools for organised content creation.
The introduction of CoAuthor represents a huge step forward in medical writing, an important component of drug development that has previously depended on traditional, manual techniques that have remained mostly unaltered over the last two decades. As medication development increasingly includes precision medicine therapies based on complex scientific discoveries, there is a growing need for more efficient data synthesis and presentation methods.
"Life S
Certara Launches Next Generation CoAuthor™ Generative AI Regulatory Writing Software
- By Anshika Mathews
- Published on
CoAuthor, created by and for medical writers, offers simplicity of use with specialised AI models tailored to life sciences, solid client-specific GPT integration, and full eCTD regulatory writing templates.
